We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRMD icon
2676
KORU Medical Systems
KRMD
$154M
$178K ﹤0.01%
24,606
+23,399
+1,939% +$208K
OVV icon
2677
Ovintiv
OVV
$17.5B
$178K ﹤0.01%
21,856
+4,619
+27% +$47.7K
ULH icon
2678
Universal Logistics Holdings
ULH
$518M
$178K ﹤0.01%
8,536
+6,888
+418% +$134K
CURO
2679
DELISTED
CURO Group Holdings Corp.
CURO
$178K ﹤0.01%
25,153
+16,976
+208% +$129K
NETI
2680
DELISTED
Eneti Inc.
NETI
$178K ﹤0.01%
12,509
+11,158
+826% +$157K
CADE
2681
DELISTED
Cadence Bank
CADE
$177K ﹤0.01%
9,175
-11,421
-55% -$244K
HSMV icon
2682
First Trust Horizon Managed Volatility Small/Mid ETF
HSMV
$39.3M
$177K ﹤0.01%
+7,284
New +$181K
SFBS
2683
ServisFirst Bancshares
SFBS
$5B
$177K ﹤0.01%
5,187
-28
-0.5% -$1K
HARP
2684
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$177K ﹤0.01%
1,044
+885
+557% +$128K
TTM
2685
DELISTED
Tata Motors Limited
TTM
$177K ﹤0.01%
19,442
+12,132
+166% +$101K
ARNA
2686
DELISTED
Arena Pharmaceuticals Inc
ARNA
$177K ﹤0.01%
2,368
-6,096
-72% -$406K
MSON
2687
DELISTED
Misonix Inc
MSON
$177K ﹤0.01%
15,029
+12,791
+572% +$166K
CHMA
2688
DELISTED
Chiasma, Inc. Common Stock
CHMA
$177K ﹤0.01%
41,101
+34,414
+515% +$165K
HTH icon
2689
Hilltop Holdings
HTH
$2.25B
$176K ﹤0.01%
8,532
+634
+8% +$12.3K
MGM icon
2690
MGM Resorts International
MGM
$11.1B
$176K ﹤0.01%
8,061
-852
-10% -$16.9K
PLPC icon
2691
Preformed Line Products
PLPC
$2.29B
$176K ﹤0.01%
3,616
+1,144
+46% +$60.5K
SKF icon
2692
ProShares UltraShort Financials
SKF
$10.4M
$176K ﹤0.01%
+952
New +$177K
SPRO icon
2693
Spero Therapeutics
SPRO
$71.8M
$176K ﹤0.01%
15,784
+13,043
+476% +$154K
APT icon
2694
Alpha Pro Tech
APT
$54.8M
$175K ﹤0.01%
11,833
+9,066
+328% +$154K
EQNR icon
2695
Equinor
EQNR
$96.3B
$175K ﹤0.01%
12,421
+8,450
+213% +$130K
RSPH icon
2696
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$796M
$175K ﹤0.01%
7,410
-27,140
-79% -$639K
ARCT icon
2697
Arcturus Therapeutics
ARCT
$223M
$174K ﹤0.01%
4,062
+3,335
+459% +$166K
HONE
2698
DELISTED
HarborOne Bancorp
HONE
$174K ﹤0.01%
21,580
+15,993
+286% +$137K
SFST icon
2699
Southern First Bancshares
SFST
$607M
$174K ﹤0.01%
7,189
+5,884
+451% +$149K
LBC
2700
DELISTED
Luther Burbank Corporation Common Stock
LBC
$174K ﹤0.01%
20,825
+16,314
+362% +$152K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.